---
title: "Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296539232.md"
description: "Inovio Pharmaceuticals (INO) shares fell 6.92% to $1.21 on Thursday, snapping an eight-day winning streak and underperforming competitors like Johnson & Johnson and Pfizer. The drop occurred amid a broader market decline, with the NASDAQ and Dow Jones falling 1.00% and 1.32% respectively. Inovio's stock is now 59.38% below its 52-week high of $2.98. Trading volume reached 4.1 million, exceeding the 50-day average."
datetime: "2026-08-20T21:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296539232.md)
  - [en](https://longbridge.com/en/news/296539232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296539232.md)
generator: "portal-rs"
---

# Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. (INO) slipped 6.92% to $1.21 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.00% to 26,067.17 and Dow Jones Industrial Average falling 1.32% to 52,759.21.

The stock's fall snapped an eight-day winning streak.

Inovio Pharmaceuticals Inc. closed 59.38% below its 52-week high of $2.98, which the company reached on September 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 2.21% to $267.37, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) fell 1.59% to $27.79.

Trading volume (4.1 M) eclipsed its 50-day average volume of 3.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-20-26 1733ET

### Related Stocks

- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors](https://longbridge.com/en/news/297235104.md)
- [Inovio publishes Q2 2026 financial results presentation focusing on INO-3107 BLA review progress](https://longbridge.com/en/news/295713543.md)
- [ANI Pharma CEO Nikhil Lalwani disposes of 5,400 common shares worth $401,220](https://longbridge.com/en/news/297093829.md)
- [Globeflex Capital L P Takes Position in ANI Pharmaceuticals, Inc. $ANIP](https://longbridge.com/en/news/296757387.md)
- [Inovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings Results, Beats Expectations By $0.15 EPS](https://longbridge.com/en/news/295718213.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**